Table 2: Results of
met analysis.
|
Cancer
type |
Fixed
effect model Overall Ratio |
|
All
cancer sites morbidity children and adults together |
*1.07 (90% CI 1.04, 1.10 (95% CI 1.03, 1.11) (99% CI 1.02, 1.12) |
|
All
cancer sites morbidity adults |
*1.11 (90% CI 1.06, 1.15) (95% CI 1.06, 1.16) (99% CI 1.04, 1.18) |
|
All
cancer sites mortality children and adults |
0.92 (90% CI
0.89, 0.96) (95% CI
0.88, 0.97) (99% CI
0.87, 0.98) |
|
All
cancer sites mortality adults |
0.92 (90%CI 0.88, 0.96) (95%CI 0.88, 0.97) (99%CI 0.86, 0.98) |
|
Lymphoma
morbidity |
*1.55 (90% CI 1.27, 1.90) (95% CI 1.22, 1.97) (99% CI 1.14, 2.12) |
|
Lymphoma
and multiple myeloma mortality |
1.17 (90% CI 0.99, 1.38) (95% CI 0.96, 1.42) (99% CI 0.91, 1.51) |
|
Childhood leukemia morbidity |
*1.35 (90% CI 1.20, 1.53) (95% CI 1.17, 1.56) (99% CI 1.12, 1.64) |
|
All
leukemia morbidity adults |
*1.24 (90%CI 1.14, 1.35) (95%CI 1.12, 1.37) (99%CI 1.09, 1.42) |
|
All leukemia mortality adults |
*1.29 (90% CI 1.16, 1.44) (95% CI 1.13, 1.47) (99% CI 1.09, 1.53) |
|
Melanoma morbidity |
*1.47 (90% CI 1.27, 1.69) (95% CI 1.24, 1.74) 99%) CI
1.18, 1.83) |
|
Breast cancer morbidity |
*1.23 (90% CI 1.12, 1.36) (95% CI 1.10, 1.39) (99% CI 1.06, 1.44) |
|
Brain
(and CNS) cancer morbidity |
*1.44 (90% CI 1.22, 1.69) (95% CI 1.18, 1.74) (99% CI 1.11, 1.85) |
|
Brain (and CNS) cancer mortality |
1.18 (90% CI 0.97, 1.43) (95% CI 0.94, 1.48) (99% CI 0.87, 1.59) |
|
Brain
cancer morbidity in children |
1.11 (90% CI 0.97, 1.28) (95% CI 0.94, 1.32) (99% CI 0.90, 1.39) |
|
Testicular cancer morbidity |
1.24 (90% CI
1.03, 1.50) ** (95% CI
0.99, 1.56) (99%CI
0.92, 1.67) |
* Statistically significant
** Borderline significant